Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease

被引:1289
作者
Palop, Jorge J. [1 ]
Chin, Jeannie
Roberson, Erik D.
Wang, Jun
Thwin, Myo T.
Bien-Ly, Nga
Yoo, Jong
Ho, Kaitlyn O.
Yu, Gui-Qiu
Kreitzer, Anatol
Finkbeiner, Steven
Noebels, Jeffrey L.
Mucke, Lennart
机构
[1] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA
[2] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94158 USA
[3] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA
[4] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA
[5] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94158 USA
[6] Baylor Coll Med, Dept Neurol, Dev Neurogenet Lab, Houston, TX 77030 USA
关键词
D O I
10.1016/j.neuron.2007.07.025
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neural network dysfunction may play an important role in Alzheimer's disease (AD). Neuronal circuits vulnerable to AD are also affected in human amyloid precursor protein (hAPP) transgenic mice. hAPP mice with high levels of amyloid-beta peptides in the brain develop AD-like abnormalities, including cognitive deficits and depletions of calcium-related proteins in the dentate gyrus, a region critically involved in learning and memory. Here, we report that hAPP mice have spontaneous nonconvulsive seizure activity in cortical and hippocampal networks, which is associated with GABAergic sprouting, enhanced synaptic inhibition, and synaptic plasticity deficits in the dentate gyrus. Many Ab-induced neuronal alterations could be simulated in nontransgenic mice by excitotoxin challenge and prevented in hAPP mice by blocking overexcitation. Aberrant increases in network excitability and compensatory inhibitory mechanisms in the hippocampus may contribute to A beta-induced neurological deficits in hAPP mice and, possibly, also in humans with AD.
引用
收藏
页码:697 / 711
页数:15
相关论文
共 88 条
[1]   Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses [J].
Almeida, CG ;
Tampellini, D ;
Takahashi, RH ;
Greengard, P ;
Lin, MT ;
Snyder, EM ;
Gouras, GK .
NEUROBIOLOGY OF DISEASE, 2005, 20 (02) :187-198
[2]   Incidence and predictors of seizures in patients with Alzheimer's disease [J].
Amatniek, JC ;
Hauser, WA ;
DelCastillo-Castaneda, C ;
Jacobs, DM ;
Marder, K ;
Bell, K ;
Albert, M ;
Brandt, J ;
Stern, Y .
EPILEPSIA, 2006, 47 (05) :867-872
[3]  
BAKST I, 1986, J NEUROSCI, V6, P1452
[4]   Knock-out mice reveal a critical antiepileptic role for neuropeptide Y [J].
Baraban, SC ;
Hollopeter, G ;
Erickson, JC ;
Schwartzkroin, PA ;
Palmiter, RD .
JOURNAL OF NEUROSCIENCE, 1997, 17 (23) :8927-8936
[5]  
Bijak Maria, 1995, Polish Journal of Pharmacology, V47, P461
[6]   Alzheimer's disease [J].
Blennow, Kaj ;
de Leon, Mony J. ;
Zetterberg, Henrik .
LANCET, 2006, 368 (9533) :387-403
[7]   The human hippocampus and spatial and episodic memory [J].
Burgess, N ;
Maguire, EA ;
O'Keefe, J .
NEURON, 2002, 35 (04) :625-641
[8]   Phenotype associated with APP duplication in five families [J].
Cabrejo, Lucie ;
Guyant-Marechal, Lucie ;
Laquerriere, Annie ;
Vercelletto, Martine ;
De la Fourniere, Francois ;
Thomas-Anterion, Catherine ;
Verny, Christophe ;
Letournel, Franck ;
Pasquier, Florence ;
Vital, Anne ;
Checler, Frederic ;
Frebourg, Thierry ;
Campion, Dominique ;
Hannequin, Didier .
BRAIN, 2006, 129 :2966-2976
[9]   Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice [J].
Chapman, PF ;
White, GL ;
Jones, MW ;
Cooper-Blacketer, D ;
Marshall, VJ ;
Irizarry, M ;
Younkin, L ;
Good, MA ;
Bliss, TVP ;
Hyman, BT ;
Younkin, SG ;
Hsiao, KK .
NATURE NEUROSCIENCE, 1999, 2 (03) :271-276
[10]   Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation [J].
Cheng, IH ;
Palop, JJ ;
Esposito, LA ;
Bien-Ly, N ;
Yan, FG ;
Mucke, L .
NATURE MEDICINE, 2004, 10 (11) :1190-1192